OrganOx
United Kingdom
acquiredacquired
acquired
Stage
2008
Founded
5
Investors
About
OrganOx develops medical technology for organ preservation, primarily using normothermic machine perfusion (NMP) to maintain donor organs outside the body, extending preservation time and enabling better assessment before transplantation.
Explore OrganOx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.